Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.50% is 61% below its 5-year average of 1.26%, near the low end of its 5-year range (0.50%–1.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 45.05% below its 12-month average of 0.90%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.50%.
DEBT TO ASSETS RATIO
0.50%
DEBT TO ASSETS RATIO AVG TTM
0.90%
DEBT TO ASSETS RATIO AVG 3Y
1.19%
DEBT TO ASSETS RATIO AVG 5Y
1.26%
DEBT TO ASSETS RATIO AVG 10Y
0.93%
DEBT TO ASSETS RATIO AVG 15Y
0.65%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-45.05%
CURRENT VS 3Y AVG
-58.42%
CURRENT VS 5Y AVG
-60.74%
CURRENT VS 10Y AVG
-46.46%
CURRENT VS 15Y AVG
-24.01%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+450.34%
vs the sector median at left
Xenon Pharmaceuticals Inc.
Market Cap
$3.54B
Debt to Assets Ratio
0.50%
TTM Avg
0.90%
3Y Avg
1.19%
5Y Avg
1.26%
Market Cap
$3.52B
Debt to Assets Ratio
0.67%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.57B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.48B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.44B
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.64B
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.38B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | $3.54B | 0.50% | 0.90% | 1.19% | 1.26% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 0.67% | N/A | N/A | N/A |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 0.03% | N/A | N/A | N/A |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | 0.03% | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | 0.02% | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.47B | 0.91% | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 0.06% | N/A | N/A | N/A |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | 0.13% | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 0.04% | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | 0.04% | N/A | N/A | N/A |
Debt/Assets
0.5%
Debt/Equity
0.01
Current Ratio
21.02
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.50% |
| 2026-03-31 | 0.54% |
| 2025-12-31 | 0.81% |
| 2025-09-30 | 1.37% |
| 2025-06-30 | 1.29% |
| 2025-03-31 | 1.17% |
| 2024-12-31 | 1.13% |
| 2024-09-30 | 1.17% |
| 2024-06-30 | 1.13% |
| 2024-03-31 | 1.13% |
| 2023-12-31 | 1.13% |
| 2023-09-30 | 1.64% |
| 2023-06-30 | 1.68% |
| 2023-03-31 | 1.62% |
| 2022-12-31 | 1.38% |
| 2022-09-30 | 0.92% |
| 2022-06-30 | 0.97% |
| 2022-03-31 | 1.47% |
| 2021-12-31 | 1.44% |
| 2021-09-30 | 1.23% |
| 2021-06-30 | 1.28% |
| 2021-03-31 | 1.09% |
| 2020-12-31 | 1.75% |
| 2020-09-30 | 0.39% |
| 2020-06-30 | 0.44% |
| 2020-03-31 | 6.91% |
| 2019-12-31 | 11.14% |
| 2019-09-30 | 16.60% |
| 2019-06-30 | 15.51% |
| 2019-03-31 | 14.35% |
| 2018-12-31 | 12.26% |
| 2018-09-30 | 11.41% |
| 2018-06-30 | 17.91% |
| 2018-03-31 | 18.21% |
| 2017-12-31 | 14.75% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
